222 related articles for article (PubMed ID: 25703294)
41. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).
Astolfi A; Urbini M; Indio V; Nannini M; Genovese CG; Santini D; Saponara M; Mandrioli A; Ercolani G; Brandi G; Biasco G; Pantaleo MA
BMC Genomics; 2015 Nov; 16():892. PubMed ID: 26531060
[TBL] [Abstract][Full Text] [Related]
42. Exome versus transcriptome sequencing in identifying coding region variants.
Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
[TBL] [Abstract][Full Text] [Related]
43. HLA typing by next-generation sequencing - getting closer to reality.
Gabriel C; Fürst D; Faé I; Wenda S; Zollikofer C; Mytilineos J; Fischer GF
Tissue Antigens; 2014 Feb; 83(2):65-75. PubMed ID: 24447174
[TBL] [Abstract][Full Text] [Related]
44. Exome sequencing in adult neurology practice: Challenges and rewards in a mixed resource setting.
Nagappa M; Bindu PS; Sinha S; Mathuranath PS; Taly AB
Clin Neurol Neurosurg; 2018 Nov; 174():48-56. PubMed ID: 30212743
[TBL] [Abstract][Full Text] [Related]
45. What we have learned from the next-generation sequencing: Contributions to the genetic diagnoses and understanding of pathomechanisms of neurodegenerative diseases.
Liu YT; Lee YC; Soong BW
J Neurogenet; 2015; 29(2-3):103-12. PubMed ID: 26059699
[TBL] [Abstract][Full Text] [Related]
46. Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease.
Obeidova L; Seeman T; Elisakova V; Reiterova J; Puchmajerova A; Stekrova J
BMC Med Genet; 2015 Dec; 16():116. PubMed ID: 26695994
[TBL] [Abstract][Full Text] [Related]
47. Application of next generation sequencing to molecular diagnosis of inherited diseases.
Zhang W; Cui H; Wong LJ
Top Curr Chem; 2014; 336():19-45. PubMed ID: 22576358
[TBL] [Abstract][Full Text] [Related]
48. The challenge for the next generation of medical geneticists.
Frebourg T
Hum Mutat; 2014 Aug; 35(8):909-11. PubMed ID: 24838402
[TBL] [Abstract][Full Text] [Related]
49. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
[TBL] [Abstract][Full Text] [Related]
50. Next generation sequencing applications for cardiovascular disease.
Kalayinia S; Goodarzynejad H; Maleki M; Mahdieh N
Ann Med; 2018 Mar; 50(2):91-109. PubMed ID: 29027470
[TBL] [Abstract][Full Text] [Related]
51. Clinical Utility of Whole Exome Sequencing and Targeted Panels for the Identification of Inborn Errors of Immunity in a Resource-Constrained Setting.
Engelbrecht C; Urban M; Schoeman M; Paarwater B; van Coller A; Abraham DR; Cornelissen H; Glashoff R; Esser M; Möller M; Kinnear C; Glanzmann B
Front Immunol; 2021; 12():665621. PubMed ID: 34093558
[TBL] [Abstract][Full Text] [Related]
52. Application of high-throughput sequencing for studying genomic variations in congenital heart disease.
Dorn C; Grunert M; Sperling SR
Brief Funct Genomics; 2014 Jan; 13(1):51-65. PubMed ID: 24095982
[TBL] [Abstract][Full Text] [Related]
53. Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects.
Tang S; Wang J; Zhang VW; Li FY; Landsverk M; Cui H; Truong CK; Wang G; Chen LC; Graham B; Scaglia F; Schmitt ES; Craigen WJ; Wong LJ
Hum Mutat; 2013 Jun; 34(6):882-93. PubMed ID: 23463613
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases.
Saudi Mendeliome Group
Genome Biol; 2015 Jun; 16(1):134. PubMed ID: 26112015
[TBL] [Abstract][Full Text] [Related]
55. Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.
Jardin F
Discov Med; 2014; 18(97):51-65. PubMed ID: 25091488
[TBL] [Abstract][Full Text] [Related]
56. Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies.
Nijman IJ; van Montfrans JM; Hoogstraat M; Boes ML; van de Corput L; Renner ED; van Zon P; van Lieshout S; Elferink MG; van der Burg M; Vermont CL; van der Zwaag B; Janson E; Cuppen E; Ploos van Amstel JK; van Gijn ME
J Allergy Clin Immunol; 2014 Feb; 133(2):529-34. PubMed ID: 24139496
[TBL] [Abstract][Full Text] [Related]
57. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
[TBL] [Abstract][Full Text] [Related]
58. [Molecular and prenatal diagnosis of a family with Fanconi anemia by next generation sequencing].
Gong Z; Yu Y; Zhang Q; Gu X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):204-7. PubMed ID: 25863087
[TBL] [Abstract][Full Text] [Related]
59. Next generation molecular diagnosis of mitochondrial disorders.
Wong LJ
Mitochondrion; 2013 Jul; 13(4):379-87. PubMed ID: 23473862
[TBL] [Abstract][Full Text] [Related]
60. Regulating whole exome sequencing as a diagnostic test.
Lapin V; Mighion LC; da Silva CP; Cuperus Y; Bean LJ; Hegde MR
Hum Genet; 2016 Jun; 135(6):655-73. PubMed ID: 27167135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
